Hepatitis Diagnostic Test Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Hepatitis Diagnostic Test Market is segmented by Test Type (Blood tests, Imaging Test and Liver Biopsy) and Geography.

Market Snapshot

Hepatitis Diagnostic Test Picture 1
Study Period:

2018 - 2026

Base Year:

2020

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

CAGR:

6 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The major shift from conventional technologies to molecular diagnostics has amplified the competence of procedures and has to pull down the dispatch time for results. Molecular diagnostics used in hepatitis testing involve genetic tests to confirm the exact strain of the causative virus. The nucleic acid assays used include HCV RNA and HBV DNA analysis tests. Hence, the availability of such advanced detection techniques is spurring the overall market growth. Furthermore, the high prevalence of hepatitis is also expected to fuel market growth. According to the U.S. Department of Health & Human Services, in 2018, most adults in their 20s and 30s made up 36.5% of newly reported chronic hepatitis C infections and this is expected to increase in the forecast period. Along with these other factors, such as increasing awareness regarding the disease may lead to the further growth of the market.

Scope of the Report

The term Hepatitis broadly means inflammation of the liver. Heavy alcohol use, some medications, toxins, and certain medical conditions can cause hepatitis. However, hepatitis is often caused due to viral infection. The most common types of viral hepatitis are hepatitis A, hepatitis B, and hepatitis C. The burden of HBV and HCV is disproportionately high in low-income and middle-income countries, particularly in Asia and Africa. Worldwide, the majority of the people with chronic HBV were infected at birth or in early childhood, and perinatal or horizontal transmission predominates in Africa and Asia.

By Test Type
Blood Tests
Liver Function Tests
Immunoassays
Nucleic Acid Tests
Imaging Test
Liver Biopsy
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Immunoassay Segment is Expected to Show Good Growth Over the Forecast Period

Immunoassays are bioanalytical methods, in which the quantitation of the analyte depends on the reaction of an antigen and an antibody. Compared to conventional tests, immunoassays have been proven to provide highly accurate results even with very small samples. The versatile applications and ease of diagnosis have made immunoassay quite popular in recent years. Also, with the rising cases of hepatitis, the market is expected to show better growth. According to WHO, in 2019, Hepatitis B prevalence is highest in the WHO Western Pacific region and the WHO African region, where 6.2% and 6.1% of the adult population is infected respectively. Hence, owing to the aforementioned factors, along with rising technological advancements are expected to further drive the market growth.

Hepatitis.png

To understand key trends, Download Sample Report

North America is Expected to Retain Largest Market Share Over the Forecast Period

North America dominated the market with the largest revenue share. The availability of advanced diagnostic tools and high awareness regarding these products are the key factors driving the growth of the market in North America. The accelerated growth in the Canadian market can be attributed to the initiatives of the government and non-government organizations. For instance, the Public Health Agency of Canada organized the World Hepatitis Day in order to increase awareness regarding hepatitis detection. Thereby, leading to a demand surge for hepatitis detection in the country.

Hepatitis Diagnostic Test Market 2

To understand geography trends, Download Sample Report

Competitive Landscape

The market is dominated by few global players which compete primarily on the basis of technological innovations. Key market players include Abbott Laboratories, Danaher Corporation, BioMerieux SA, Bio-Rad Laboratories Inc, Diasorin S.p.A, F. Hoffmann-La Roche AG, Hologic Inc, MedMira Inc, Qaigen Inc, and Siemens Healthineers.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Burden of Hepatitis

      2. 4.2.2 Introduction of Molecular Diagnostics for the Diagnosis of Hepatitis

      3. 4.2.3 Increasing Awareness Regarding The Disease

    3. 4.3 Market Restraints

      1. 4.3.1 Limited Facilities or Services For Hepatitis Testing

      2. 4.3.2 Limited Access to Reliable and Low-Cost HBV and HCV Diagnostics

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Test Type

      1. 5.1.1 Blood Tests

        1. 5.1.1.1 Liver Function Tests

        2. 5.1.1.2 Immunoassays

        3. 5.1.1.3 Nucleic Acid Tests

      2. 5.1.2 Imaging Test

      3. 5.1.3 Liver Biopsy

    2. 5.2 Geography

      1. 5.2.1 North America

        1. 5.2.1.1 United States

        2. 5.2.1.2 Canada

        3. 5.2.1.3 Mexico

      2. 5.2.2 Europe

        1. 5.2.2.1 Germany

        2. 5.2.2.2 United Kingdom

        3. 5.2.2.3 France

        4. 5.2.2.4 Italy

        5. 5.2.2.5 Spain

        6. 5.2.2.6 Rest of Europe

      3. 5.2.3 Asia Pacific

        1. 5.2.3.1 China

        2. 5.2.3.2 Japan

        3. 5.2.3.3 India

        4. 5.2.3.4 Australia

        5. 5.2.3.5 South Korea

        6. 5.2.3.6 Rest of Asia-Pacific

      4. 5.2.4 Middle-East and Africa

        1. 5.2.4.1 GCC

        2. 5.2.4.2 South Africa

        3. 5.2.4.3 Rest of Middle-East and Africa

      5. 5.2.5 South America

        1. 5.2.5.1 Brazil

        2. 5.2.5.2 Argentina

        3. 5.2.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Danaher Corporation (Beckman Coulter Inc)

      3. 6.1.3 BioMerieux SA

      4. 6.1.4 Bio-Rad Laboratories Inc

      5. 6.1.5 Diasorin S.p.A

      6. 6.1.6 F. Hoffmann-La Roche AG

      7. 6.1.7 Hologic Inc

      8. 6.1.8 MedMira Inc

      9. 6.1.9 Qaigen Inc

      10. 6.1.10 Siemens Healthineers

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Hepatitis Diagnostic Test Market market is studied from 2018 - 2026.

The Hepatitis Diagnostic Test Market is growing at a CAGR of 6% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

  • Abbott Laboratories
  • Bio-Rad Laboratories Inc
  • F. Hoffmann-La Roche AG
  • Siemens Healthineers
  • BioMerieux SA

Are the major companies operating in Hepatitis Diagnostic Test Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!